Healthcare

The partnership aims to mitigate drug shortages, democratize access, enhance flexibility and streamline procurement.

HB1150 prohibits state permits to pharmacies owned by pharmacy benefit managers effective Jan. 1, 2026.

The order directs the Department of Health and Human Services to take steps to significantly reduce drug prices for American patients.

Yuflyma is a high-concentration and citrate-free formulation of Humira biosimilar, approved for multiple inflammatory indications.

The scholarships will help reduce financial barriers for student pharmacists.

This kit is intended to ease the lives of those living with long-term severe spasticity conditions.

Lurasidone hydrochloride tablets are an atypical antipsychotic.

The legislation would save more than $800 million over 10 years and brings lower-cost medicines to patients sooner, AAM said.